Literature DB >> 6723088

Blood pressure and metabolic effects of cortisol and deoxycorticosterone in man.

J A Whitworth, D Saines, B A Scoggins.   

Abstract

We have previously shown that ACTH administration (1 mg/day) for 5 days raises systolic blood pressure (BP) by some 20 mmHg in both normotensive and hypertensive subjects, accompanied by hypokalaemia, urinary Na retention, a rise in fasting blood glucose and a fall in plasma renin concentration (PRC). In the present study cortisol and deoxycorticosterone (DOC) were infused for 5 days in 7 and 6 subjects respectively at rates appropriate for conditions of ACTH stimulation to determine whether the effects of ACTH could be reproduced by either steroid. Cortisol infusion increased systolic BP from a control of 108 +/- 7 mmHg to 129 +/- 7 mmHg on day 5, p less than 0.001. Plasma [Na] increased from 137 +/- 1 to 139 +/- 1 mmol/l (p less than 0.01), plasma [K] fell from 3.8 +/- 0.1 to 3.6 +/- 0.1 mmol/l (p less than 0.05); blood glucose rose from 3.9 +/- 0.2 to 4.7 +/- 0.2 mmol/l (p less than 0.001); PRC fell from 26 +/- 7 to 12 +/- 3 mu iu /ml (p less than 0.05); renin substrate rose from 1629 +/- 140 to 2206 +/- 453 pmol AI/ml, (p less than 0.05); urine Na excretion fell from 93 +/- 19 to 41 +/- 10 mmol on day 2 (p less than 0.05) and rose to 209 +/- 31 mmol 48 hrs after infusion (p less than 0.001); urine output rose from 2.0 +/- 0.35 to 2.89 +/- 0.46 L on day 5, (p less than 0.01). Plasma cortisol levels were similar to those seen with ACTH treatment. DOC infusion was associated with a fall in diastolic BP (control 64.2 +/- 4.0 mmHg, day 5 57.0 +/- 4.2 mmHg, p less than 0.01). Urine Na excretion fell from 77 +/- 12 mmol/day to 49 +/- 8 mmol/day on day 1, (p = 0.06) and body weight rose from 76.0 +/- 5.8 kg to 76.8 +/- 5.9 kg day 5 (p less than 0.001). Thus in man, cortisol infusion (in contrast to DOC) at rates appropriate for conditions of ACTH stimulation reproduces both the BP and metabolic effects of ACTH. Whether cortisol acts to raise blood pressure by a classical glucocorticoid mechanism or by a hypertensinogenic mechanism is not known.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6723088     DOI: 10.3109/10641968409044039

Source DB:  PubMed          Journal:  Clin Exp Hypertens A        ISSN: 0730-0077


  7 in total

1.  Biobehavioral effects of extended salt loading and conflict stress in intact baboons.

Authors:  J S Turkkan
Journal:  J Exp Anal Behav       Date:  1994-03       Impact factor: 2.468

Review 2.  Factors involved in the pathogenesis of hypertensive cardiovascular hypertrophy. A review.

Authors:  B Dahlöf
Journal:  Drugs       Date:  1988       Impact factor: 9.546

3.  Effect of interval training program on white blood cell count in the management of hypertension: A randomized controlled study.

Authors:  S Lamina; C G Okoye
Journal:  Niger Med J       Date:  2011-10

Review 4.  Cardiovascular consequences of cortisol excess.

Authors:  Judith A Whitworth; Paula M Williamson; George Mangos; John J Kelly
Journal:  Vasc Health Risk Manag       Date:  2005

5.  Effect of alcohol on blood pressure.

Authors:  Sara Tasnim; Chantel Tang; Vijaya M Musini; James M Wright
Journal:  Cochrane Database Syst Rev       Date:  2020-07-01

6.  Role of the renin-angiotensin system, renal sympathetic nerve system, and oxidative stress in chronic foot shock-induced hypertension in rats.

Authors:  Tao Dong; Jing-Wei Chen; Li-Li Tian; Lin-Hui Wang; Ren-Di Jiang; Zhe Zhang; Jian-Bing Xu; Xiao-Dong Zhao; Wei Zhu; Guo-Qing Wang; Wan-Ping Sun; Guo-Xing Zhang
Journal:  Int J Biol Sci       Date:  2015-04-26       Impact factor: 6.580

7.  Cross-Sectional Blood Metabolite Markers of Hypertension: A Multicohort Analysis of 44,306 Individuals from the COnsortium of METabolomics Studies.

Authors:  Panayiotis Louca; Ana Nogal; Aurélie Moskal; Neil J Goulding; Martin J Shipley; Taryn Alkis; Joni V Lindbohm; Jie Hu; Domagoj Kifer; Ni Wang; Bo Chawes; Kathryn M Rexrode; Yoav Ben-Shlomo; Mika Kivimaki; Rachel A Murphy; Bing Yu; Marc J Gunter; Karsten Suhre; Deborah A Lawlor; Massimo Mangino; Cristina Menni
Journal:  Metabolites       Date:  2022-06-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.